1132969-89-1

Basic information

• Product Name: (2S,3S,4S,E)-((1S,2R)-2-(N-benzyl-2,4,6-trimethylphenylsulfonamido)-1-phenylpropyl) 3-hydroxy-7-iodo-2,4,6-trimethylhept-6-enoate
• Synonyms: (2S,3S,4S,E)-((1S,2R)-2-(N-benzyl-2,4,6-trimethylphenylsulfonamido)-1-phenylpropyl) 3-hydroxy-7-iodo-2,4,6-trimethylhept-6-enoate
• CAS NO: 1132969-89-1
• Molecular Weight: 717.709
• Mol File: 1132969-89-1.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (2S,3S,4S,E)-((1S,2R)-2-(N-benzyl-2,4,6-trimethylphenylsulfonamido)-1-phenylpropyl) 3-hydroxy-7-iodo-2,4,6-trimethylhept-6-enoate(CAS DataBase Reference)
• NIST Chemistry Reference: (2S,3S,4S,E)-((1S,2R)-2-(N-benzyl-2,4,6-trimethylphenylsulfonamido)-1-phenylpropyl) 3-hydroxy-7-iodo-2,4,6-trimethylhept-6-enoate(1132969-89-1)
• EPA Substance Registry System: (2S,3S,4S,E)-((1S,2R)-2-(N-benzyl-2,4,6-trimethylphenylsulfonamido)-1-phenylpropyl) 3-hydroxy-7-iodo-2,4,6-trimethylhept-6-enoate(1132969-89-1)

Safety Data

• Hazardous Substances Data: 1132969-89-1(Hazardous Substances Data)

Upstream product

• 1032592-14-5 (2S,4E)-2,4-dimethyl-5-iodo-4-penten-1-ol 
• 58113-69-2 (2S)-2-methyl-4-pentyn-1-ol 
• 1379802-54-6 C₁₆H₂₁NO₂ 
• 1132969-88-0 (S,E)-N-((1R,2R)-1-hydroxy-1-phenylpropan-2-yl)-5-iodo-N,2,4-trimethylpent-4-enamide 
• 1032592-19-0 (2S,4E)-2,4-dimethyl-5-iodo-4-pentenal 
• 187324-67-0 (1S,2R)-2-(N-benzyl-N-mesitylenesulfonyl)amino-1-phenyl-1-propyl propionate 
• 145412-54-0 dicyclohexyl(((trifluoromethyl)sulfonyl)oxy)borane 

Downstream Products

• 1132969-90-4 C₄₁H₅₈INO₅SSi 
• 1132969-84-6 methyl (2Z,4E,6R,7S,8S,10E,14S)-14-((4R,5S,6R)-6-((2S,3S)-3-(tert-butyldiphenylsilyloxy)butan-2-yl)-2,2,5-trimethyl-1,3-dioxan-4-yl)-14-hydroxy-2-methoxy-4,6,8,10-tetramethyl-7-(triethylsilyloxy)tetradeca-2,4,10-trien-12-ynoate 
• 1132970-12-7 (2Z,4E,6R,7S,8S,10E,12E,14S)-methyl 14-((4R,5S,6R)-6-((2S,3S)-3-(tert-butyldiphenylsilyloxy)butan-2-yl)-2,2,5-trimethyl-1,3-dioxan-4-yl)-7-hydroxy-2,14-dimethoxy-4,6,8,10-tetramethyltetradeca-2,4,10,12-tetraenoate 
• 1132970-13-8 (2Z,4E,6R,7S,8S,10E,12E,14S)-methyl 14-((4R,5S,6R)-6-((2S,3S)-3-(tert-butyldiphenylsilyloxy)butan-2-yl)-2,2,5-trimethyl-1,3-dioxan-4-yl)-7-(formyloxy)-2,14-dimethoxy-4,6,8,10-tetramethyltetradeca-2,4,10,12-tetraenoate 
• 1132969-98-2 methyl (2Z,4E,6R,7S,8S,10E,12E,14S,15R,16S,17R,18S,19S)-19-(tert-butyldiphenylsilyloxy)-7,15,17-trihydroxy-2,14-dimethoxy-4,6,8,10,16,18-hexamethylicosa-2,4,10,12-tetraenoate 
• 1132970-14-9 (3Z,5E,7R,8S,9S,11E,13E,15S,16R)-16-((2S,3R,4S,5S)-5-(tert-butyldiphenylsilyloxy)-3-hydroxy-4-methylhexan-2-yl)-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyloxacyclohexadeca-3,5,11,13-tetraen-2-one 
• 1379802-76-2 (2Z,4E,6R,7S,8S,10E,12E,14S,15R,16S,17R,18S,19S)-methyl 19-(tert-butyldiphenylsilyloxy)-7-(formyloxy)-15,17-dihydroxy-2,14-dimethoxy-4,6,8,10,16,18-hexamethylicosa-2,4,10,12-tetraenoate 

Relevant articles and documents

Total synthesis of bafilomycin A1

A convergent synthesis of bafilomycin A1, a potent inhibitor of V-type ATPases, is presented. The synthesis relies on the zinc triflate mediated diastereoselective addition of a complex enyne to a sensitive aldehyde as the key fragment coupling. A ruthenium-catalyzed trans-reduction of the resulting propargylic enyne efficiently installs the required C10-C13 trans,trans-diene subunit, implementing an alternative strategy to traditional palladium-catalyzed cross-coupling strategies. A highly selective oxidation of a secondary hydroxyl group in a triol sets the stage for the completion of the synthesis. Copyright